InMode (INMD) Cash from Investing Activities (2018 - 2026)
InMode (INMD) posted Cash from Investing Activities of $109.1 million for Q1 2026, up 300.78% sequentially from $27.2 million in Q4 2025, and up 44.54% YoY from $75.5 million in Q1 2025.
InMode (INMD) Cash from Investing Activities (2018 - 2026) Analysis & Trends
InMode has reported Cash from Investing Activities for 9 years, with the latest figure at $109.1 million in Q1 2026.
- Quarterly Cash from Investing Activities rose 44.54% year-over-year to $109.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $219.6 million (down 22.95% YoY) and the FY2025 annual result came in at $186.0 million, up 14.69% from the prior year.
- Cash from Investing Activities advanced to $109.1 million in Q1 2026 per INMD's latest filing, from $27.2 million in the prior quarter.
- Over five years, Cash from Investing Activities peaked at $114.1 million in Q3 2024 and troughed at -$69.8 million in Q3 2023.
- A 5-year average of $12.5 million and a median of $11.7 million in 2025 frame the typical range for Cash from Investing Activities.
- The widest YoY moves for Cash from Investing Activities: up 647.89% in 2023, down 117.11% in 2023.
- Over 5 years, Cash from Investing Activities stood at -$38.3 million in 2022, then tumbled by 34.79% to -$51.6 million in 2023, then jumped by 250.84% to $77.8 million in 2024, then plunged by 65.02% to $27.2 million in 2025, then jumped by 300.78% to $109.1 million in 2026.
- According to Business Quant data, Cash from Investing Activities over the past three periods registered $109.1 million, $27.2 million, and $11.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.36 Bn | 194.75 Bn | 7.27 Bn | -673.00 Mn |
| 2 | Stryker | 129.99 Bn | 126.52 Bn | 4.50 Bn | -639.00 Mn |
| 3 | Medtronic | 120.03 Bn | 110.81 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 74.30 Bn | 73.76 Bn | 3.85 Bn | -1.96 Bn |
| 5 | Edwards Lifesciences | 52.61 Bn | 48.36 Bn | 1.35 Bn | -193.20 Mn |
| 6 | Dexcom | 34.71 Bn | 32.76 Bn | 830.00 Mn | 329.80 Mn |
| 7 | GE HealthCare Technologies | 34.24 Bn | 32.13 Bn | 2.18 Bn | -115.00 Mn |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn | -22.08 Mn |
| 9 | Steris | 23.30 Bn | 22.81 Bn | 684.20 Mn | -108.50 Mn |
| 10 | InMode | 914.04 Mn | 498.87 Mn | 71.52 Mn | 37.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 109.10 Mn |
| Mar 31, 2026 | 109.10 Mn |
| Dec 31, 2025 | 27.22 Mn |
| Dec 31, 2025 | 27.22 Mn |
| Sep 30, 2025 | 11.67 Mn |
| Sep 30, 2025 | 11.67 Mn |
| Jun 30, 2025 | 71.66 Mn |
| Jun 30, 2025 | 71.66 Mn |
| Mar 31, 2025 | 75.49 Mn |
| Mar 31, 2025 | 75.49 Mn |
| Dec 31, 2024 | 77.82 Mn |
| Dec 31, 2024 | 77.82 Mn |
| Sep 30, 2024 | 114.06 Mn |
| Sep 30, 2024 | 114.06 Mn |
| Jun 30, 2024 | 17.73 Mn |
| Jun 30, 2024 | 17.73 Mn |
| Mar 31, 2024 | -47.39 Mn |
| Mar 31, 2024 | -47.39 Mn |
| Dec 31, 2023 | -51.59 Mn |
| Dec 31, 2023 | -51.59 Mn |